Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 6/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.61 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6503622 | 0.90 | PTGES (0.49) | PTGESALOX5PTGS1ALOX5APPTGS2 | |
| SCHEMBL14413899 | 0.86 | PTGES (0.67) | PTGESALOX5PTGS1ALOX5APPTGS2 | |
| SCHEMBL12203021 | 0.85 | PTGES (0.65) | PTGESALOX5PTGS1ALOX5APPTGS2 | |
| SCHEMBL6505066 | 0.84 | PTGES (0.44) | PTGESALOX5PTGS1ALOX5APPTGS2 | |
| SCHEMBL8397926 | 0.84 | ALOX5 (0.45) | PTGESALOX5PTGS1ALOX5APPTGS2 | |
| SCHEMBL3984072 | 0.82 | PTGES (0.77) | PTGESALOX5PTGS1ALOX5APPTGS2 | |
| SCHEMBL6505733 | 0.80 | PTGES (0.45) | PTGESALOX5PTGS1ALOX5APPTGS2 | |
| SCHEMBL6505736 | 0.80 | ALOX5 (0.66) | PTGESALOX5PTGS1ALOX5APPTGS2 | |
| SCHEMBL6495185 | 0.80 | ALOX5 (0.51) | PTGESALOX5PTGS1ALOX5APPTGS2 | |
| Licofelone SCHEMBL7738810 | 0.79 | PTGES (0.83) | PTGESALOX5PTGS1ALOX5APPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009056077-A2 | A NEW METHOD OF MANUFACTURING 2-(6-(4-CHLOROPHENYL)-2,2-DIMETHYL-7-PHENYL-2,3-DIHYDRO-LH-PYRROLIZINE-5-YL)ACETIC ACID (LICOFELONE) | ZENTIVA, A.S. (CZ) | 2009-05-07 | — | — | WO | disclosed |